Endoscopic Submucosal Dissection Market Size & Share, by Product (Gastroscopes & Colonoscopes, Knives, Injection Agents); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); Indication (Stomach Cancer, Colon Cancer, Esophageal Cancer) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5662
  • Published Date: Apr 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024 - 2036

Endoscopic Submucosal Dissection Market size is anticipated to reach USD 51 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of endoscopic submucosal dissection was over USD 42 billion. The primary growth driver for the market is the relentless evolution of technology within endoscopy procedures. The continuous refinement of tools and imaging capabilities in the field of ESD not only enhances the precision of diagnostic procedures but also significantly improves the efficacy of therapeutic interventions.

Furthermore, advancements in electrosurgical tools, incorporating features like tissue-specific energy delivery and enhanced cutting capabilities, contribute to the procedural efficiency and safety of ESD. These innovations empower healthcare professionals to perform intricate dissections with reduced collateral damage to surrounding tissues, thereby optimizing patient outcomes. According to a recent report, the U.S. was the biggest exporter of medical technology devices in the world.

Additionally, ESD is a minimally invasive technique used for the removal of early-stage gastrointestinal tumors, particularly in the esophagus, stomach, and colorectal region.

Get more information on this report: Request Free Sample PDF

Endoscopic Submucosal Dissection Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing incidence of gastrointestinal diseases - The rising incidence of gastrointestinal diseases, specifically colorectal cancer and gastric cancer, is a significant growth driver for the endoscopic submucosal dissection (ESD) market. According to a recent report, there were an estimated 1.8 million new cases of colorectal cancer worldwide in 2020.
  • Moreover, this escalating prevalence underscores the urgent need for advanced diagnostic and therapeutic interventions, such as ESD. As these diseases continue to affect a growing number of individuals globally, the endoscopic submucosal dissection market is positioned to play a crucial role in their management and treatment.
  • Preference for minimally invasive procedures - The global shift towards minimally invasive procedures is a driving force for the ESD market. An increase has been noted in the preference for minimally invasive interventions over traditional surgeries in the last decade. Patients and healthcare providers favor these procedures due to their associated benefits, including shorter recovery times, reduced postoperative complications, and improved overall patient outcomes. Growing preference positions ESD as a forefront choice in gastrointestinal interventions, further fueling market growth.
  • Technological advancements in endoscopic tools - Continuous innovation in endoscopic tool is a pivotal growth driver for the endoscopic submucosal dissection market. Advanced tools, including robotic-assisted platforms and high-definition diagnostic imaging systems, are transforming the landscape of gastrointestinal interventions.
  • Furthermore, this highlights the tangible impact of technological advancements on enhancing the precision and outcomes of ESD interventions, making them more attractive to healthcare providers and patients alike. Growing awareness regarding the importance of early diagnosis of gastrointestinal diseases contributes to the demand for diagnostic procedures like ESD.


  • Procedural complexity and skill requirement: Performing ESD procedures requires a high level of skill and expertise. The intricate nature of the dissection process demands advanced training for endoscopists, making it a challenging technique for widespread implementation.
  • The limited availability of highly skilled professionals may hinder the accessibility of ESD procedures, particularly in regions with a shortage of trained endoscopists. Healthcare facilities, especially in resource-constrained settings, may find it challenging to invest in ESD technology, limiting its accessibility to a broader patient population.
  • The higher cost of equipment and training hinders the market growth
  • Lack of awareness among patients restricts the use of ESD

Endoscopic Submucosal Dissection Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2023)

USD 42 Billion

Forecast Year Market Size (2036)

USD 51 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Endoscopic Submucosal Dissection Segmentation

Product (Gastroscopes & Colonoscopes, Knives, Injection Agents)

The gastroscopes & colonoscopes segment in the endoscopic submucosal dissection market is estimated to gain a revenue share of 60% in the year 2036. The segment growth can be attributed to the ongoing advancements in colonoscopic techniques, including improved maneuverability and visualization capabilities, which contribute to the success rates of ESD procedures. With the aging global population, there is a corresponding increase in the prevalence of colorectal diseases.

Colonoscopes have become indispensable tools in addressing the higher incidence of colorectal cancer and other gastrointestinal conditions in the elderly population. The age-related rise in colorectal diseases contributes to the sustained growth of the colonoscope segment within the ESD market. They are integral to the detection and treatment of colorectal cancer through ESD procedures. The alarming rise in colorectal cancer incidence worldwide underscores the crucial role of colonoscopes in early diagnosis and intervention. The American Cancer Society reported over 147,000 new cases of colorectal cancer in the United States in 2020.    

End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers)

The hospital segment in the endoscopic submucosal dissection market is expected to garner a significant share in the year 2036 due to the increasing awareness among patients regarding minimally invasive treatment options that fuels the demand for ESD procedures. In addition, hospitals, as primary healthcare providers, witness a surge in patients seeking advanced, less invasive alternatives. To meet this demand, hospitals invest in the necessary infrastructure, training, and technology, positioning themselves at the forefront of ESD adoption and growth.

Furthermore, government initiatives and healthcare policies play a pivotal role in shaping the healthcare landscape, including the adoption of advanced medical procedures like ESD. Various supportive policies and funding initiatives encourage hospitals to invest in infrastructure and training for ESD procedures. As governments prioritize the improvement of healthcare services, hospitals become key beneficiaries, driving growth in the hospitals segment. The hospital, as hubs for medical innovation and advancement, are quick to adopt cutting-edge technologies.

Our in-depth analysis of the global market includes the following segments:



  • Gastroscopes & Colonoscopes
  • Knives
  • Injection Agents


     End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers


  • Stomach Cancer
  • Colon Cancer
  • Esophageal Cancer

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Endoscopic Submucosal Dissection Industry - Regional Synopsis

APAC Market Forecast

The endoscopic submucosal dissection market in the Asia Pacific region is projected to hold the largest revenue share of 47% by the end of 2036. The Asia Pacific region, particularly countries like Japan, China, and South Korea, experiences a disproportionately high burden of gastric cancer. Moreover, the prevalence of this disease creates a substantial market for ESD procedures, which are increasingly recognized as effective interventions for early-stage gastric cancer. The pressing need to address the high incidence of gastric cancer serves as a primary growth driver for the ESD market in the Asia Pacific region. According to a recent report, Asia accounts for nearly 50% of the global incidence of gastric cancer.

The region is at the forefront of adopting cutting-edge endoscopic technologies. The ongoing advancements, including high-definition imaging and real-time monitoring, enhance the precision and success rates of ESD procedures. This commitment to technological progress positions the region as a hub for innovation in endoscopy, driving growth in the ESD market.

North American Market Statistics

The endoscopic submucosal dissection market in the North American region is projected to hold the second-largest share during the forecast period. Colorectal cancer is a significant health concern in North America, particularly in the United States. The high incidence of colorectal cancer creates a substantial demand for effective treatment methods such as ESD. As a result, healthcare providers in North America are increasingly adopting ESD procedures as an essential tool in the fight against colorectal cancer.

North America is at the forefront of integrating cutting-edge technologies into healthcare practices. Continuous advancements in endoscopic imaging technologies, including high-definition scopes and advanced software, enhance the precision of ESD procedures. This commitment to technological innovation positions North America as a hub for advanced endoscopic techniques, driving growth in the ESD market.

The prevalence of GERD in North America contributes to a higher incidence of Barrett's esophagus and other gastrointestinal conditions. ESD procedures are increasingly recognized as effective interventions for treating early-stage lesions associated with GERD. As a result, the demand for ESD in North America is fueled by the need to address GERD-related complications.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Endoscopic Submucosal Dissection Landscape

    • Olympus Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Fujifilm Holdings Corporation
    • Boston Scientific Corporation
    • Medtronic plc
    • Cook Medical
    • Hoya Corporation
    • Karl Storz GmbH & Co. KG
    • CONMED Corporation
    • ERBE Elektromedizin GmbH
    • Johnson & Johnson

In the News

  • Medtronic plc - The global leader in healthcare technology, Medtronic plc announced that it has expanded its partnership with Cosmo Intelligent Medical Devices which is a subsidiary of Cosmo Pharmaceuticals. This partnership aims to revolutionize endoscopy by the integration of AI to improve patients’ outcomes. The collaboration also focused on innovative AI platforms like AI Access to host multiple third party AI applications.
  • Johnson & Johnson - Johnson & Johnson and Shockwave Medical have entered into an agreement in which Johnson & Johnson will acquire shares of Shockwave. This acquisition of Shockwave extends the company’s MedTech’s position in cardiovascular intervention. Additionally, the acquisition will complement the company’s leadership position in heart recovery to make it a category leader in the MedTech markets within the cardiovascular intervention.   

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5662
  • Published Date: Apr 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidence of gastrointestinal diseases, preference for minimally invasive procedures, and technological advancements in endoscopic tools are the major factors driving the market growth.

The market size of endoscopic submucosal dissection is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Olympus Corporation, Fujifilm Holdings Corporation, Boston Scientific Corporation, Medtronic plc, Cook Medical, Hoya Corporation, Karl Storz GmbH & Co. KG, CONMED Corporation, ERBE Elektromedizin GmbH, Johnson & Johnson, and others.

The gastroscopes & colonoscopes segment is anticipated to garner the largest market share of 60% by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share of 47% by the end of 2036 and provide more business opportunities in the future.
Endoscopic Submucosal Dissection Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying